340 related articles for article (PubMed ID: 16552496)
1. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
2. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
3. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
[TBL] [Abstract][Full Text] [Related]
4. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
7. [The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population].
Wang R; Zhang JH; Li Y; Wen DG; He M; Wei LZ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1089-92. PubMed ID: 12899785
[TBL] [Abstract][Full Text] [Related]
8. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas.
Lewis RC; Bostick RM; Xie D; Deng Z; Wargovich MJ; Fina MF; Roufail WM; Geisinger KR
Cancer Res; 2003 Dec; 63(23):8549-53. PubMed ID: 14679024
[TBL] [Abstract][Full Text] [Related]
10. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
12. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients.
Song JH; Kim CJ; Cho YG; Park YK; Nam SW; Yoo NJ; Lee JY; Park WS
Neoplasma; 2007; 54(3):235-9. PubMed ID: 17447856
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
[TBL] [Abstract][Full Text] [Related]
14. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma.
Catarino RJ; Breda E; Coelho V; Pinto D; Sousa H; Lopes C; Medeiros R
Head Neck; 2006 Jul; 28(7):603-8. PubMed ID: 16691558
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
[TBL] [Abstract][Full Text] [Related]
18. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study.
Sameer AS; Parray FQ; Dar MA; Nissar S; Banday MZ; Rasool S; Gulzar GM; Chowdri NA; Siddiqi MA
Mol Med Rep; 2013 Mar; 7(3):811-5. PubMed ID: 23354584
[TBL] [Abstract][Full Text] [Related]
20. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
